Mediq rss

Exchange ratio final 2011 dividend

Fri, 04 May 2012 00:00:00 +0200

Mediq, international supplier of medical devices and pharmaceuticals, has set the exchange ratio for the optional stock dividend for 2011.

Hans Janssen re-appointed Chief Financial Officer at Mediq

Wed, 02 May 2012 00:00:00 +0200

The Supervisory Committee of Mediq, international supplier of medical devices and pharmaceuticals, have re-appointed Hans Janssen Chief Financial Officer (CFO) as of 1 May 2012.

Q1 2012: Lower result Pharmacies Netherlands

Wed, 25 Apr 2012 06:51:00 +0200

Further growth of sales and result at Direct & Institutional

Financial highlights
Net sales
Up 1% to € 654.3 million due to growth at Direct & Institutional; decrease at Pharmacies Netherlands and Pharmacies Poland.

EBITA from ordinary activities
Down 10% to € 27.2 million due to decrease of € 4.4 million at Pharmacies Netherlands; EBITA at Direct & Institutional up 10%.

Net result
Down 21% to € 13.9 million due to lower EBITA and higher amortisation of customer relationships.

Net result per share from ordinary activities
Down 6% to € 0.30 due to lower EBITA from ordinary activities, partly compensated by a lower number of shares outstanding.

Cash flow
Cash flow from operating activities up significantly, to € 46.1 million, mainly due to improvement of working capital.

Outlook 2012
Where we previously expected a decrease of EBITA at Pharmacies Netherlands compared to 2011, we now expect that decrease to be substantial. The outlook for D&I and Pharmacies Poland is unchanged; at both segments we expect an increase in EBITA.

Mediq transfers pension scheme to industry pension fund PMA

Wed, 25 Apr 2012 00:00:00 +0200

Mediq, international supplier of medical devices and pharmaceuticals, announces that it is voluntarily joining Pensioenfonds Medewerkers Apotheken (PMA – Pharmacy Assistants’ Pension Fund) with immediate effect. To ensure the transfer proceeds successfully, Mediq will contribute a maximum amount of € 8.6 million in transition costs – including the compensation for missed indexation in prior years. In addition, Mediq will offer a compensation scheme enabling employees to adapt gradually to the new contribution over a five-year period, totalling € 1.4 million. The members of the trade unions FNV Bondgenoten and CNV Vakmensen have agreed to the transaction. The supervisory authority, the Dutch Central Bank DNB, has announced not to object to this collective transfer.

Mediq increases its homecare market share in the US

Mon, 23 Apr 2012 00:00:00 +0200

Utrecht, 23 April 2012 – Mediq, international supplier of medical devices and pharmaceuticals, acquires Diabetes Specialty Centre (DSC). DSC delivers insulin pumps, continuous glucose monitors and the related supplies to frequent-user, insulin-dependent diabetics. Mediq has been active in the US through Byram Healthcare since 2008. This acquisition will consolidate Byram’s number 4 position in this large but fragmented market.

Decisions annual General Meeting of Shareholders

Thu, 12 Apr 2012 00:00:00 +0200

Utrecht, 12 April 2012 – Yesterday the annual General Meeting of Shareholders of Mediq, has chosen to replace the current full statutory two-tier board regime by a mitigated two-tier board system.

“Diabetes in Focus” Photo Contest Spotlights Diabetes in Daily Life

Fri, 30 Mar 2012 00:00:00 +0200

International Photo and Video Contest in the Run-up to World Diabetes Day

The 2012 edition of the World Diabetes Day Platform photo contest is being called “Diabetes in Focus.” Following the success of the 2010 and 2011 editions in the Netherlands and Germany, the campaign is also being held in the United States this year. Another exciting change is that the contest is open not only to photographers, but also to filmmakers – young and old, amateur and professional. The World Diabetes Day Platform organizes Diabetes 24/7 in conjunction with the international company Mediq. Through the photo competition, Mediq hopes to draw attention specifically to the plight of young people suffering from diabetes. Submissions will be accepted through October 1, 2012 at www.diabetes24-7.nl.

Mediq completes acquisition in Germany

Thu, 29 Dec 2011 12:54:00 +0100

The German competition authority has approved Mediq’s acquisition of assist. The acquisition will make Mediq the second player in the German market.

Hospitals choose Mediq

Wed, 28 Dec 2011 10:17:00 +0100

Home care guaranteed for patients

As of 1 January 2012, the issuing of specialised pharmaceuticals to patients (like TNF-alpha blockers) will be the responsibility of hospitals rather than pharmacies. Mediq believes it is important for patients to receive specialist pharmaceutical care where they most need it. This may be at patients’ homes, at their own public pharmacy or at a hospital pharmacy. Twelve hospitals have already chosen the specialised Mediq Pharma Services for their patients.

Touching diabetes images

Mon, 14 Nov 2011 16:57:00 +0100

Today at World Diabetes Day the jury announces the winners of photo competition Diabetes 24/7. The jury, among others Anne Hoogendoorn, known from The Voice of Holland and top photographer Corbino, made their choice out of close to 500 entries. Diabetes 24/7 is an initiative of Platform World Diabetes Day in collaboration with Mediq. World Diabetes Day is worldwide the most important awareness campaign for diabetes.

Mediq makes substantial acquisition in Germany

Wed, 09 Nov 2011 17:34:00 +0100

Mediq, international supplier of medical devices and pharmaceuticals, acquires the German company assist. assist covers Germany supplying medical devices for tube feeding, infusion therapy, ostomy, incontinence and wound care to patients at home. Mediq is already active in these areas in other countries. To date, in Germany Mediq only supplies devices to diabetes patients. This acquisition will make Mediq the second player in the German market. The € 95 million acquisition price is financed from existing credit facilities.

Mediq improves use of pharmaceuticals and helps to prevent hospital admissions

Thu, 03 Nov 2011 13:58:00 +0100

Mediq concludes multi-year contract with insurer

Mediq Pharmacy is introducing a new healthcare program. General practitioners and pharmacists together decide whether or not a patient is receiving the correct treatment, whether or not a patient is taking it in the correct way (therapy compliance) or whether or not the pharmaceutical treatment is in line with the most recent guidelines and scientific insights. It’s the first time a pharmaceutical program provides - fully automated and at a glance - insight into whether the pharmaceuticals should be adjusted. Better use of pharmaceuticals reduces the chance of complications and prevents unnecessary hospital admissions. Healthcare insurers of Achmea are the first to embrace the new program per 2012.

Q3 2011: Solid growth Direct & Institutional

Wed, 26 Oct 2011 07:15:00 +0200

Lower result pharmacies

Financial highlights

Net sales
Up 2% to € 671.8 million due to acquisitions and organic growth at Direct & Institutional.

EBITA from ordinary activities*
Down 13% to € 27.9 million due to lower results at Pharmacies Netherlands and Pharmacies Poland.

Net earnings per share from ordinary activities*
Down 4% to € 0.33 due to lower EBITA from ordinary activities partly compensated by lower financial costs and a lower number of shares outstanding.

Cash flow
Cash flow from operating activities of € 54.6 million, benefiting from improved working capital position.

Outlook 2011
EBITA of € 123 million to € 127 million reconfirmed.

Mediq acquires 5.87% of its own shares from SSAO

Tue, 06 Sep 2011 07:53:00 +0200

As from today, Mediq, the international supplier of medical devices and pharmaceuticals, owns the 3,535,215 Mediq shares formerly held by Stichting Samenwerking Apothekers OPG (SSAO). As a result, these shares carry no voting rights or dividend rights.

Start of 'SMEER 'M' campaign for children with eczema in Zeeland province

Mon, 05 Sep 2011 10:27:00 +0200

Admiraal De Ruyter Hospital and Mediq Pharmacy are starting special meetings for children who suffer from eczema as well as for their parents. The 'SMEER 'M' (moisten it) sessions are meant to introduce these children to others who suffer the same problem and to exchange tips on how best to handle their eczema. The first session will start at the hospital in Goes on 19 September. Contact the hospital (eczeem@adrz.nl) or any of the Mediq pharmacies in Goes for registration.

Mediq announces exchange ratio for interim dividend

Mon, 22 Aug 2011 08:40:00 +0200

Mediq, international supplier of medical devices and pharmaceuticals, has set the exchange ratio for the interim optional stock dividend for the financial year 2011.

Q2 2011: Further international growth Mediq D&I

Thu, 28 Jul 2011 00:00:00 +0200

Q2: 12% increase of operating result (EBITA) from ordinary activities

Financial highlights

Net sales	Up 6% to € 684.4 million driven by Direct & Institutional.
EBITA*	Increase of EBITA from ordinary activities by 12% to € 29.7 million, due to improved results at Direct & Institutional and Pharmacies Netherlands.
Net result	Up 7% to € 17.0 million, due to higher operational result, a negative effect of higher amortisation of customer relationships and relatively low taxation in Q2 2010.
Other developments	Consolidation of Stichting Samenwerking Apothekers OPG as of 28 July leads to decrease in number of Mediq shares outstanding by 5.87%.
Outlook 2011	EBITA* between € 123 million and € 127 million.

Mediq completes acquisition Medicus Plesner in Norway

Fri, 01 Jul 2011 14:08:00 +0200

The Norwegian competition authority has approved Mediq’s acquisition of Medicus Plesner AS.

Mediq will appeal decision Utrecht District Court

Wed, 22 Jun 2011 18:46:00 +0200

Mediq, international supplier of medical devices and pharmaceuticals, absolutely disagrees with the decision rendered by the Utrecht District Court that Mediq may no longer use its logos and house style in the Netherlands. Mediq will appeal the decision.

Anne Hoogendoorn of The Voice of Holland in jury of Diabetes 24/7 Photo competition

Mon, 06 Jun 2011 17:14:00 +0200

“I’ve never let my diabetes hold me back”

The jury for the Diabetes 24/7 Photo Competition has been chosen. Anne Hoogendoorn, known from tv show The Voice of Holland, has had diabetes since she was twelve years old and is the youngest of the four ambassadors of the Diabetes Fund. The other jury members include top photographer Corbino and the actress Izaira Kersten.

New marketing campaign Mediq Pharmacy

Wed, 18 May 2011 14:19:00 +0200

The new TV commercial for Mediq Pharmacy will be launched today. The pay-off for the campaign will be: Mediq Pharmacy; attention for all of your health-related questions. The positioning centres on Mediq Pharmacies’ accessibility and personal advice. Click here for a sneak preview.

Launch of Diabetes 24/7 photo competition as a build-up to World Diabetes Day

Mon, 16 May 2011 10:38:00 +0200

After last year’s success, the World Diabetes Day Platform is once again challenging professional and amateur photographers to illustrate diabetes. The World Diabetes Day Platform organises Diabetes 24/7 in cooperation with Mediq. With the photo competition, Mediq asks for special attention for young people with diabetes. Photos can be submitted via http://www.diabetes24-7.nl through to 14 October.

Mediq strengthens market position in Sweden

Wed, 11 May 2011 08:03:00 +0200

Mediq, international supplier of medical devices and pharmaceuticals, has acquired part of Medic24’s activities in Sweden. These activities concern the supply of medical devices to GPs and specialists, which expands Mediq Sverige’s existing activities in this customer segment. The acquisition ties in with Mediq’s strategy of growing its Direct and Institutional activities.

Mediq announces exchange ratio for dividend

Thu, 05 May 2011 08:32:00 +0200

Mediq, international supplier of medical devices and pharmaceuticals, has set the exchange ratio for the optional stock dividend for 2010.

Mediq starts in France with acquisition NM Médical

Wed, 04 May 2011 07:55:00 +0200

Mediq, international supplier of medical devices and pharmaceuticals, acquires the French company NM Médical. The acquisition of NM Médical will make Mediq a leading supplier of medical devices to GPs in France. Mediq did not previously have any activities in France and, following the acquisition, Mediq will be active in 15 countries. The purchase price of €17 million will be financed from available cash resources.

Q1 2011: 14% growth operating result (EBITA) from ordinary activities

Wed, 27 Apr 2011 07:30:00 +0200

Financial highlights

Net sales
Up 7%, mainly due to acquisitions at Direct & Institutional. Organic sales at D&I rose 2%.
EBITA
EBITA from ordinary activities up 14% to € 30.1 million due to higher results at D&I, Pharmacies Netherlands and Pharmacies Poland.
Net result
Decreased by 14% to € 17.6 million, mainly due to the effect of non operational income in 2010. Net earnings per share from ordinary activities up 6%.
Outlook 2011
Unchanged from that announced at the publication of the full-year 2010 results

Acquisition PBG strengthens position Mediq Direct & Institutional

Wed, 27 Apr 2011 07:13:00 +0200

Mediq, international provider of medical devices and pharmaceuticals, acquires PBG. PBG is a supplier of medical devices to diabetics, GPs, obstetricians and other healthcare providers. The acquisition consolidates Mediq’s position on the Dutch market. The purchase price of € 40 million will be financed from available cash resources.

Launch of Mediq Pharmacy Online

Fri, 15 Apr 2011 08:45:00 +0200

Innovative pharmaceutical care

Mediq, international supplier of pharmaceuticals and medical devices, is launching Mediq Pharmacy Online. Everyone can order prescription pharmaceuticals and self-care products on www.mediq.nl. Medication control and good pharmaceutical care are of primary importance. Patients opt for ease of ordering online or visiting their local pharmacy.

Mr. Visser reappointed as member of Supervisory Board

Wed, 13 Apr 2011 17:09:00 +0200

The Annual General Meeting of Shareholders of Mediq, international provider of pharmaceuticals and medical devices, has today approved the reappointment of Mr Visser, for a subsequent term of four years. Biense Visser has been a member of the Supervisory Board since 2003. He is the chairman of the Remuneration Committee.

Mediq Pharmacist Willem van de Spijker ‘Care talent’ of the year

Wed, 13 Apr 2011 11:07:00 +0200

Utrecht, 13 April 2011 – Healthcare magazine ‘Zorgvisie’ has voted
managing pharmacist Willem van de Spijker of Mediq Pharmacy 't Heelhuis in Helmond, the most talented young care manager of the year. The 31-year-old Willem van de Spijker wins this title with his project 'Diafarmazob', in which GPs and pharmacists work closely together to optimize the use of pharmaceuticals of people with diabetes.

Mediq strengthenes position in Norway

Mon, 11 Apr 2011 00:00:00 +0200

Mediq, international supplier of pharmaceuticals and medical devices, has acquired the Norwegian company Medicus Plesner AS. Medicus Plesner supplies medical devices to patients (‘direct’). This acquisition significantly strengthens Mediq’s market position in Norway.

Q4 2010:International growth Mediq

Thu, 17 Feb 2011 00:00:00 +0100

Q4: Further increase operating result

Financial highlights Q4 2010

Net sales Up
11% mainly due to acquisitions at Direct & Institutional (10%). Organic sales edged down 1%, reflecting a decrease at Pharmacies Netherlands; 3% organic sales growth at Direct & Institutional. Exchange rate effects were 2%

Operating result
Up 23% to € 29.4 million excluding non-operational items, due to higher results at Direct & Institutional and Pharmacies Netherlands, and up 14% excluding a one-off reorganisation provision of € 1.7 million at Direct & Institutional in Q4 2009 as well.

Net result
Up 28% due to the higher operating result and lower taxation.

Mediq acquires Dutch company Romedic

Tue, 01 Feb 2011 00:00:00 +0100

Mediq, international supplier of pharmaceuticals and medical devices, has acquired Romedic BV. Romedic is the market leader in the field of nebuliser therapy in the Netherlands. This acquisition significantly strengthens Mediq’s position in this market segment.

Mediq sells Anzag stake

Wed, 22 Dec 2010 11:18:00 +0100

Utrecht, 16 December 2010 – Mediq, international supplier of pharmaceuticals and medical devices, has sold its 6.76%-stake in the listed German pharmaceutical wholesaler Andreae-Norris Zahn AG (Anzag).

The shares have been sold for a total amount of € 18.5 million to an undisclosed buyer. The position in Anzag has been non-core for Mediq for some time now.

Mediq disappointed about reduction dispensing fee

Thu, 16 Dec 2010 12:43:00 +0100

Utrecht, 16 December 2010 – Mediq, international supplier of pharmaceuticals and medical devices, is disappointed about the decision taken by the Dutch Healthcare Authority (NZa) to reduce the dispensing fee. The NZa policy and the expansion of the preference policy will have a combined negative effect of approximately € 8 million on Mediq’s operating result in 2011 (compared to 2010).

Mediq Pharmacy launches national Repeat convenience campaign

Mon, 22 Nov 2010 15:10:00 +0100

Through its new online service Repeat convenience, Mediq Pharmacy will arrange repeat prescriptions for patients with GPs. Following the GP’s approval patients will be automatically notified when their medication is ready to be collected from the pharmacy. Repeat convenience is an extra service for patients taking medication on a long-term (chronic) basis. There are some 4.5 million people in the Netherlands with a chronic condition, taking medication for elevated cholesterol levels for instance, or gastric acid inhibitors for gastrointestinal problems.

Mediq wins Henri Sijthoff award for best annual report

Tue, 02 Nov 2010 12:00:00 +0100

Mediq, the international supplier of pharmaceuticals and medical devices, won the Henri Sijthoff award for best financial reporting for 2009 in the mid-cap and small-cap category. Yesterday, jury member Erik van de Merwe presented the award to Marc van Gelder, CEO of Mediq, in the Artis Zoo conference room in Amsterdam.

Mediq acquires company seconding nursing personnel

Thu, 28 Oct 2010 14:32:00 +0200

As from today, Mediq has acquired Medisource, a company seconding mainly nursing personnel. Mediq is increasingly delivering pharmaceuticals and medical supplies directly to people in home care situations, often in combination with advice and instruction by nursing personnel. The acquisition of Medisource ties in with Mediq’s strategy to expand services at people’s homes.

Medisource has about 150 staff, including nurse practitioners, doctors, healthcare practice support staff and doctor’s assistants. They are among others deployed in home healthcare settings, at GPs, Municipal Health Services (GGD) and Mental Health Care (GGZ) institutions, hospitals and pharmaceutical companies. Mediq Direct already uses the services of Medisource. The head office will continue to be located in Rijswijk. Medisource’s sales amounted to around € 5 million in 2009.

The acquisition of Medisource enables all business units of Mediq to deploy nurse practitioners directly if required. Marcel van den Broek, Executive Vice President of Mediq Direct & Institutional: “The acquisition of Medisource marks an important step for Mediq towards its aim of offering comprehensive therapies at home. This will enable us to provide even better support for our customers at home, taking into account their personal wishes and circumstances.”

Healthy growth operating result from ordinary activities

Wed, 27 Oct 2010 07:14:00 +0200

Financial highlights
Net sales Overall increase of 1%, mainly due to acquisitions at Direct & Institutional (7%) and the sale of our pharmaceutical activities in Belgium (- 8%).

Operating result Up 26%, excluding non-operational items, driven mainly by higher operational results at Direct & Institutional and Pharmacies Netherlands. When we also exclude the reorganisation provision of € 4.1 million in Q3 2009 at Pharmacies Netherlands, operating result increased by 7%.

Net result down 6%, mainly due to non-taxable book gain on the sale of our pharmaceutical activities in Belgium in Q3 2009.

Outlook for 2010
Operating result between € 112 million and € 116 million (including € 3.5 million book gain on Anzag in Q3 2010).
Organic sales growth at the lower end of the earlier indicated range of 2 − 3% at constant exchange rates.

Operational highlights
Direct & Institutional
Sales growth of 24%, mainly due to acquisition in the Nordics.
Growth of EBITA from ordinary activities of 14%.
Amortisation of customer relations on acquisition in the Nordics amounting to € 1.6 million.

Pharmacies Netherlands
Operating result after adjusting for provision in Q3 2009 is up € 2.3 million.
Reorganisation is progressing ahead of schedule.

Pharmacies International
Organic growth at both Polish wholesaler and pharmacies.
Operating result lower due to reorganisation provision and higher costs national distribution centre.

Sjoerd van Keulen new Chairman of Mediq’s Supervisory Board

Mon, 06 Sep 2010 12:00:00 +0200

The Supervisory Board of Mediq, international supplier of pharmaceuticals and medical devices, has appointed Sjoerd van Keulen as Chairman. Sjoerd van Keulen succeeds Fokko van Duyne, who earlier this year announced his wish to step down from the Supervisory Board. Sjoerd van Keulen joined Mediq’s Supervisory Board in April 2010.

Princess Margriet attends official opening of Mediq’s head office

Fri, 03 Sep 2010 12:00:00 +0200

Today her Royal Highness Princess Margriet today attended the symposium on young people and diabetes in Mediq’s new head office. Mediq organized the symposium in connection with the official opening of the new building. The striking glass head office of Mediq, international supplier of pharmaceuticals and medical devices, is sited along the A2 motorway at Leidsche Rijn in Utrecht.

Mediq announces exchange ratio for interim dividend

Wed, 18 Aug 2010 18:17:22 +0200

Mediq, international supplier of pharmaceuticals and medical supplies, has set the exchange ratio for the interim optional stock dividend for the financial year 2010.

Underlying operating result up 15%

Thu, 29 Jul 2010 12:00:00 +0200

Financial highlights

Net sales
Decrease of 3% due to sale of Belgian pharmaceutical activities (- 8%), partly offset by organic growth (1%), recent acquisition in Nordics (2%) and currency effects (2%).
Operating result
Up 15%, excluding non-operational and one-off items, driven mainly by Direct & Institutional.
− Non-operational items (Anzag share price changes and the 2009 sale & leaseback in Norway) had an effect of - € 9.9 million.
− One-off items (acquisition costs and reorganisation provision) in 2010 had an effect of
- € 4.8 million.
Operating result including the above items decreased by 31% on balance.
Outlook for 2010
− Operating result of between € 108 million and € 112 million.
− Organic sales growth of 2 − 3% at constant exchange rates. This replaces the previous outlook of an organic sales growth of 3 − 5%.

Operational highlights

Direct & Institutional
− Sales growth of 11%, mainly due to acquisition in Nordics.
− Acquisition consolidated as of 31 May; integration on track.
− Growth of operating result from ordinary activities of 13%.
Pharmacies Netherlands
− Unchanged operating result, after adjusting for reorganisation provision of € 2.9 million.
− Reorganisation on track.
− Good progress of centralisation of repeat medication.
Pharmacies International
− Sales decline due to sale of Belgian activities and decrease at Polish wholesaling.
− Organic growth of Polish pharmacies in line with market.
− Operating result lower due to higher costs of national distribution centre.

Mediq finalizes acquisition in the Nordics

Mon, 31 May 2010 12:00:00 +0200

Mediq, international provider of pharmaceuticals and medical devices, has today finalized the acquisition of the Healthcare Trade business of Oriola-KD.

Mediq invites youngsters with diabetes to theatre show Candy

Fri, 14 May 2010 12:00:00 +0200

Mediq, an international supplier of pharmaceuticals and medical devices, is organising seven free theatrical performances for young people with diabetes in collaboration with the Dutch Diabetes Fund (Diabetes Fonds). Izaira Kersten and Floris van Tilburg will be on stage in ‘Candy’, directed by Barry Atsma. Candy is a theatrical performance which shows, with a sense of humour, what life with diabetes is about. Young people with diabetes aged 12 to 20 can sign up on www.mediqdirect.nl/candy.

Acquisition makes Mediq No. 1 in the Nordics

Wed, 12 May 2010 12:00:00 +0200

Mediq acquires Healthcare Trade business of Oriola-KD

Mediq, international provider of pharmaceuticals and medical devices, announces the acquisition of the Healthcare Trade business of Oriola-KD. Oriola-KD is a listed Finnish company and a leading player in pharmaceuticals and healthcare trade. By taking over the Healthcare Trade business, Mediq becomes the largest provider of medical devices to hospitals and other care institutions in Finland, Sweden, Denmark, Norway and the Baltic states, which considerably strengthens Mediq’s Direct & Institutional position in Europe. The acquisition price of € 85 million will be financed from existing cash and credit lines. The acquisition is expected to contribute directly to earnings per share.

Mediq announces exchange ratio for dividend

Thu, 29 Apr 2010 12:00:00 +0200

Mediq, international supplier of pharmaceuticals and medical supplies, has set the exchange ratio for the optional stock dividend for 2009.

Substantial growth operating and net result

Wed, 28 Apr 2010 07:05:59 +0200

Financial highlights
Net sales : down 4% due to disposal of Belgian pharmacy activities (- 8%) partly compensated by organic growth (2%) and currency effect (2%)
Operating result : up 28%; operating result from ordinary activities rose 6%, partly due to continuing growth Direct & Institutional
Net result : up by € 6.2 million to € 20.5 million

Operational highlights
Direct & Institutional
− Sales growth of 4%
− Growth of operating result of 15%; increase result international activities
− Small acquisitions in the Netherlands and Denmark completed

Pharmacies Netherlands
− Good progress centralisation of repeat medication
− Expansion assortment private label products
− Positive development of result under the influence of cost savings
− Reorganisation on track

Pharmacies International
− Sales decrease due to sale of Belgian activities and organic decline of wholesaling sales
− Sales growth at pharmacies outpaces the market
− Operating result lower due to start-up costs new distribution centre

Sjoerd van Keulen appointed as member of Supervisory Board of Mediq

Thu, 08 Apr 2010 12:00:00 +0200

Mediq, international provider of pharmaceuticals and medical supplies, today appointed Sjoerd van Keulen as a member of the Supervisory Board at the General Meeting of Shareholders. Mr van Keulen is the intended successor of the current Chairman of the Supervisory Board, Mr van Duyne, who wishes to step down in the second half of 2010. Wim van den Goorbergh has been reappointed as a member of the Supervisory Board for a period of four years and will therefore continue to serve as Chairman of the Audit Committee. The proposal to enable shareholders to elect to receive dividend in cash or in shares with effect from the final dividend for 2009 was also adopted at the Meeting.

Acquisition strengthens Mediq's market leadership in Denmark

Wed, 10 Mar 2010 12:00:00 +0100

As of today, Mediq Danmark has acquired Opco A/S, the number four provider of medical supplies to general practitioners and specialists in Denmark. The acquisition strengthens Mediq’s leading market position in Denmark and ties in with Mediq’s strategy to expand its Direct and Institutional activities.